Barbara Pistilli

43PUBLICATIONS

233CO-AUTHORS

Development cooperationMolecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Tumour immunology

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (43)

Sort by Publication Date:

|Jun 08, 2026

Diversity, equity, and inclusion as scientific rigor: progress during challenging times.

|Jun 08, 2026

Diversity, equity, and inclusion as scientific rigor: progress during challenging times.

|Mar 09, 2026

VIKTORIA-1 Trial of Gedatolisib Plus Fulvestrant With or Without Palbociclib in Hormone Receptor-Positive/HER2-/PIK3CA Wild-Type Advanced Breast Cancer.

Sara A Hurvitz, Rachel M Layman, Giuseppe Curigliano

|Jan 21, 2026

Sacituzumab Govitecan plus Pembrolizumab for Advanced Triple-Negative Breast Cancer.

Sara M Tolaney, Evandro de Azambuja, Kevin Kalinsky

|Dec 29, 2025

OPERA-01: a phase III study of palazestrant for ER+, HER2- advanced breast cancer after CDK4/6 inhibitor therapy.

Barbara Pistilli, Meritxell Bellet Ezquerra, Lucia Del Mastro

|Dec 15, 2025

Patritumab deruxtecan in breast cancer treatment: a drug evaluation.

Adina Sabau, Jessica Paparo, Rasha Cheikh-Hussin

Pageof 8

Frequent Collaborators

13 joint publications

Fabrice André

13 joint publications

Ines Vaz-Luis

12 joint publications

Antonio Di Meglio

10 joint publications

Suzette Delaloge

Anne-Laure Martin

Magali Lacroix-Triki

Stefan Michiels

Paul-Henri Cottu

Fernanda Mosele

Sibille Everhard

Frequent Collaborators

13 joint publications

Fabrice André

13 joint publications

Ines Vaz-Luis

12 joint publications

Antonio Di Meglio

10 joint publications

Suzette Delaloge